Literature DB >> 29366545

Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.

G Sadeghi1, M Ebrahimi-Rad2, S F Mousavi3, M Shams-Ghahfarokhi4, M Razzaghi-Abyaneh5.   

Abstract

OBJECTIVE: Non-Candida albicans (NCA) species now account for a significant part of clinical candidiasis worldwide. In the present study, epidemiology and antifungal susceptibility profile of NCA isolated from various forms of candidiasis were studied with special focus on their phylogenetic relationship by ITS sequencing. PATIENTS AND METHODS: Seventy-nine NCA isolates were isolated from skin and nail scrapings (67.0%), vaginal discharges (8.8%), blood (8.8%), sputa (5.0%), urine (5.0%), oral swabs (2.6%), biopsy and eye tumor, each (1.4%). These isolates were identified by morphological, biochemical and molecular (ITS sequencing) techniques. In vitro antifungal susceptibility of the isolates to fluconazole (FCZ) was tested according to the CLSI method (M27-S4).
RESULTS: Among a total number of 79 cases of proven NCA infections, C. parapsilosis (36.8%) was the most prevalent species followed by C. glabrata (32.9%), C. orthopsilosis (11.4%), C. tropicalis (8.9%), C. krusei (5.0%) and C. guilliermondii (5.0%). The susceptibility to FCZ was assessed for C. parapsilosis (96.5%), C. orthopsilosis (88.9%), C. tropicalis (85.7%) and C. guilliermondii (50.0%). C. glabrata and C. krusei isolates were not susceptible to FCZ. NCA species were distributed in various phylogenetic clades including C. glabrata (1), C. tropicalis (3), C. parapsilosis (6) and C. orthopsilosis, C. krusei and C. guilliermondii (each 2).
CONCLUSION: C. parapsilosis and C. glabrata were the most predominant NCA species involve in the etiology of candidiasis. C. orthopsilosis was reported from superficial candidiasis. Taken together, our results further substantiate the increasing importance of the involvement of NCA species in the etiology of candidiasis.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antifungal susceptibility; Broth microdilution; Candidiasis; Fluconazole; ITS sequencing; Non-Candida albicans species

Mesh:

Substances:

Year:  2018        PMID: 29366545     DOI: 10.1016/j.mycmed.2017.12.008

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  23 in total

1.  Caenorhabditis elegans as a Model System To Assess Candida glabrata, Candida nivariensis, and Candida bracarensis Virulence and Antifungal Efficacy.

Authors:  Ainara Hernando-Ortiz; Estibaliz Mateo; Marcelo Ortega-Riveros; Iker De-la-Pinta; Guillermo Quindós; Elena Eraso
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

Review 2.  Fungal infections in pediatric neurosurgery.

Authors:  Adrian Caceres; Maria Luisa Avila; Marco Luis Herrera
Journal:  Childs Nerv Syst       Date:  2018-08-18       Impact factor: 1.475

3.  Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance.

Authors:  Csaba Papp; Katica Kocsis; Renáta Tóth; László Bodai; Jesse R Willis; Ewa Ksiezopolska; Nancy E Lozoya-Pérez; Csaba Vágvölgyi; Hector Mora Montes; Toni Gabaldón; Joshua D Nosanchuk; Attila Gácser
Journal:  mSphere       Date:  2018-11-14       Impact factor: 4.389

4.  Postantifungal effect of anidulafungin against Candida albicans, Candida dubliniensis, Candida africana, Candida parapsilosis, Candida metapsilosis and Candida orthopsilosis.

Authors:  S Gil-Alonso; G Quindós; E Eraso; N Jauregizar
Journal:  Rev Esp Quimioter       Date:  2019-03-08       Impact factor: 1.553

Review 5.  The glyoxylate cycle and alternative carbon metabolism as metabolic adaptation strategies of Candida glabrata: perspectives from Candida albicans and Saccharomyces cerevisiae.

Authors:  Shu Yih Chew; Wallace Jeng Yang Chee; Leslie Thian Lung Than
Journal:  J Biomed Sci       Date:  2019-07-13       Impact factor: 8.410

6.  Moonlighting proteins are variably exposed at the cell surfaces of Candida glabrata, Candida parapsilosis and Candida tropicalis under certain growth conditions.

Authors:  Justyna Karkowska-Kuleta; Dorota Satala; Oliwia Bochenska; Maria Rapala-Kozik; Andrzej Kozik
Journal:  BMC Microbiol       Date:  2019-07-03       Impact factor: 3.605

Review 7.  The potential of respiration inhibition as a new approach to combat human fungal pathogens.

Authors:  Lucian Duvenage; Carol A Munro; Campbell W Gourlay
Journal:  Curr Genet       Date:  2019-06-06       Impact factor: 3.886

8.  Colombian Essential Oil of Ruta graveolens against Nosocomial Antifungal Resistant Candida Strains.

Authors:  Matthew Gavino Donadu; Yeimmy Peralta-Ruiz; Donatella Usai; Francesca Maggio; Junior Bernando Molina-Hernandez; Davide Rizzo; Francesco Bussu; Salvatore Rubino; Stefania Zanetti; Antonello Paparella; Clemencia Chaves-Lopez
Journal:  J Fungi (Basel)       Date:  2021-05-14

9.  Efficacy of gel-based artificial saliva on Candida colonization and saliva properties in xerostomic post-radiotherapy head and neck cancer patients: a randomized controlled trial.

Authors:  Aroonwan Lam-Ubol; Oranart Matangkasombut; Dunyaporn Trachootham; Supanat Tarapan; Vanthana Sattabanasuk; Sineepat Talungchit; Wannaporn Paemuang; Tawaree Phonyiam; Orapin Chokchaitam; On-Ong Mungkung
Journal:  Clin Oral Investig       Date:  2020-08-10       Impact factor: 3.573

10.  Cutaneous candidiasis in Tehran-Iran: from epidemiology to multilocus sequence types, virulence factors and antifungal susceptibility of etiologic Candida species.

Authors:  Golnar Sadeghi; Mina Ebrahimi-Rad; Masoomeh Shams-Ghahfarokhi; Zahra Jahanshiri; Esmat Mirabzadeh Ardakani; Ali Eslamifar; Seyed Fazlollah Mousavi; Mehdi Razzaghi-Abyaneh
Journal:  Iran J Microbiol       Date:  2019-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.